Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of Telmisartan Compared With Losartan — Stella

Home/Diabetic Nephropathies/Efficacy and Safety of Telmisartan Compared With Losartan

View on ClinicalTrials.gov

Recruiting

Back to Diabetic Nephropathies trials

Efficacy and Safety of Telmisartan Compared With Losartan

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

South Korea

Severance Hospital, Seoul

Key details

Phase

Post-approval study

Sponsor

Chong Kun Dang Pharmaceutical

Enrollment target

~98 participants

Started

April 2023

Primary completion

October 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

19 Years – 75 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.